LEON : Enabling Nano Now

LEON Team at the 4th LNP Formulation & Process Development Summit – Meet Us in Boston!

  • Event

We’re excited to announce that the LEON team will be attending the 4th LNP Formulation & Process Development Summit in Boston from April 14–16, 2025.

Visit us at stand 10 and learn more about our Innovative FR-JET® Technology and our advanced products!

  • Live Demonstration of NANOlab® – See our technology in action
  • Expert Presentation – Our Senior Scientist Dr. Blerina Shkodra, will present: “A Holistic Approach for Reliable GMP Manufacturing of Nanoparticle Formulations at All Scales”
  • Discover Collaboration Opportunities – Let’s shape the future of LNP manufactturing together

Schedule a meeting – Contact us in advance to set up a meeting and discuss how we can collaborate.

About LEON

Based in Planegg/Munich, leon-nanodrugs GmbH is a pharmatech company specializing in the development and commercialization of equipment for the encapsulation of genetic material and other pharmaceutical active substances into nanoparticles, such as lipid nanoparticles (LNPs).

The company leverages its proprietary FR-JET®  technology to build innovative solutions. Its equipment portfolio includes NANOscreen® for formulation screening, NANOlab® for process development, as well as NANOme® and NANOus® for GMP manufacture. These systems are suitable for both individualized scales and commercial production, and the company further supports its clients by offering formulation and process development services.

LEON’s platform aims to empower pharmaceutical companies, small biotech, research institutes, and CDMOs to capitalize on advancements in advanced therapies.

For general information and enquiries please email info@leon-nanodrugs.com